Chronicle Academy
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Impact of Tildrakizumab on Patient Reported Outcomes in Patients With Moderate-to-severe Psoriasis in Canada (NCT07370766) | Chronicle Academy | 2025-11-25 |
Track Chronicle Academy automatically
Every clearance here is in the API, with alerts when new ones post.